AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Search Results for: "National Institute of Mental Health"

Vaginal Ring May Cut HIV Infection Risk if Used Consistently

Vaginal ring - cropped July 2016

NIH Clinical Trial Will Clarify Relationship between Ring Adherence, HIV Infection Risk A new exploratory analysis of data from the ASPIRE study has found that using a drug-infused vaginal ring most or all of the time reduced the risk of HIV infection in women by at least 56 percent. This finding is being reported today…

NIH Expands Investment in HIV Cure Research

Logo for National Institute of Allergy and Infectious Disease

Six Research Teams to Lead Collaborative Investigations Worldwide The National Institutes of Health has awarded approximately $30 million in annual funding over the next five years to six research collaborations working to advance basic medical science toward an HIV cure. The awards comprise the second iteration of the Martin Delaney Collaboratory: Towards an HIV-1 Cure…

Global Effort to End AIDS Would Save Millions of Lives

NIH Director blog - HIV virus with AIDS ribbons - cropped June 2016

Almost 37 million people around the world are now infected with human immunodeficiency virus (HIV), the virus that causes AIDS [1]. But many don’t know they are infected or lack access to medical care. Even though major strides have been made in treating the infection, less than half receive antiretroviral therapy (ART) that could prevent…

White House Meeting on HIV Stigma Examines Interventions, Measures, Actions

White House Meeting on HIV Stigma: Research for a Robust Response

Summary: On March 3, ONAP and NIH co-hosted the White House Meeting on HIV Stigma: Research for a Robust Response. As we approach the 35th anniversary of the first case reports of what would later come to be known as HIV/AIDS, we can rightfully celebrate that we now have an array of effective tools to prevent…

NIAID to Fund Further Study of Dapivirine Vaginal Ring for HIV Prevention Investment in HOPE Trial Augments Development of Next-Generation Prevention Tools

NIAID image - vaginal ring - ASPIRE study

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today that it would move forward with an open-label extension study of an HIV prevention tool for women: a silicone ring that continuously releases the experimental antiretroviral drug dapivirine in the vagina. The new study builds on…

Words Matter: Communicating to End HIV-Related Stigma

Rich Wolitski - headshot - March 2016

Words matter. They can motivate, empower, and lift people up. They can also do a great deal of damage and tear people down. I was reminded of this in many different ways at the meeting on HIV stigma that the Office of National AIDS Policy (ONAP) and the National Institute of Mental Health (NIMH) recently…

Vaginal Ring Provides Partial Protection from HIV in Large Multinational Trial

Woman holding the dapivirine vaginal ring tested in the NIH-funded ASPIRE study.
Credit: International Partnership for Microbicides

NIH-Funded Study Finds Protective Effect Strongest in Women over Age 25 A ring that continuously releases an experimental antiretroviral drug in the vagina safely provided a modest level of protection against HIV infection in women, a large clinical trial in four sub-Saharan African countries has found. The ring reduced the risk of HIV infection by…

Early Antiretroviral Therapy Prevents Non-Aids Outcomes in HIV-Infected People, NIH-Supported Study Finds

NIH logo

New Findings Illustrate Manifold Benefit of Therapy Starting antiretroviral therapy early not only prevents serious AIDS-related diseases, but also prevents the onset of cancer, cardiovascular disease, and other non-AIDS-related diseases in HIV-infected people, according to a new analysis of data from the Strategic Timing of AntiRetroviral Treatment (START) study, the first large-scale randomized clinical trial to…